News & Investors
09. November 2022 - 0:00 (CEST)
Epigenomics AG reports financial results for the first nine months 2022
Read more19. September 2022 - 0:00 (CEST)
Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs
Read more19. September 2022 - 0:00 (CEST)
Epigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test
Read more09. September 2022 - 0:00 (CEST)
Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
Read more15. August 2022 - 0:00 (CEST)
Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG
Read more10. August 2022 - 0:00 (CEST)
